As of December 2024, Human Stem Cells Institute has a market cap of $57.13M. This makes Human Stem Cells Institute the world's 23035th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $81.50M | 2.80% |
2023 | $79.28M | 64.36% |
2022 | $48.23M | -45.99% |
2021 | $89.30M | 201.10% |
2020 | $29.66M | 193.76% |
2019 | $10.10M | 64.64% |
2018 | $6.13M | -31.39% |
2017 | $8.94M | -36.29% |
2016 | $14.03M | 72.73% |
2015 | $8.12M | -8.73% |
2014 | $8.90M | -41.16% |
2013 | $15.12M | 43.19% |
2012 | $10.56M | 36.72% |
2011 | $7.73M | -22.77% |
2010 | $10.00M | -29.86% |
2009 | $14.26M | - |